Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer
J. Natl. Cancer Inst 2021 Mar 31;[EPub Ahead of Print], N Chic, SJ Luen, P Nuciforo, R Salgado, D Fumagalli, F Hilbers, Y Wang, E de Azambuja, I Làng, S Di Cosimo, C Saura, J Huober, A Prat, S LoiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.